1. No patent protection for Invisishield so nothing novel about the product;
2. No TGA approval;
3. No sales of any consequence;
4. No capital from LDA capital; and
5. No requotation of the securities.
More drivel from phoney Maloney. His claim that the stock was the third most heavily traded on the ASX is telling. This company (if you can call it that) is more interested in in its shares trading than in its products trading.
1. No patent protection for Invisishield so nothing novel about...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SKN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $2.357M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $1.627K | 406.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3206433 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 1042585 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SKN (ASX) Chart |